OMX Ventures
North America, Illinois, United States, Lincolnshire
Description
OMX Ventures is investing at the convergence of biology and computing.
Investor Profile
OMX Ventures has made 18 investments, with 2 in the past 12 months and 50% as lead.
Stage Focus
- Series A (39%)
- Seed (39%)
- Series B (11%)
- Series D (6%)
- Pre Seed (6%)
Country Focus
- United States (83%)
- United Kingdom (17%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Health Care
- Life Science
- Therapeutics
- Medical
- Pharmaceutical
- Clinical Trials
- Machine Learning
- Women's
- Artificial Intelligence (Ai)
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
